PL3976021T3 - Tri(beta-hydroksymaślan) glicerolu do zastosowania w leczeniu i zapobieganiu przemijającym atakom niedokrwiennym neuronów - Google Patents
Tri(beta-hydroksymaślan) glicerolu do zastosowania w leczeniu i zapobieganiu przemijającym atakom niedokrwiennym neuronówInfo
- Publication number
- PL3976021T3 PL3976021T3 PL19930919.6T PL19930919T PL3976021T3 PL 3976021 T3 PL3976021 T3 PL 3976021T3 PL 19930919 T PL19930919 T PL 19930919T PL 3976021 T3 PL3976021 T3 PL 3976021T3
- Authority
- PL
- Poland
- Prior art keywords
- hydroxybutyrate
- beta
- treating
- transient ischemic
- ischemic attacks
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2019/034592 WO2020242478A1 (en) | 2019-05-30 | 2019-05-30 | Glyceryl tris (beta-hydroxybutyrate) and neuronal transient ischemic attacks |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3976021T3 true PL3976021T3 (pl) | 2025-07-21 |
Family
ID=73552030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19930919.6T PL3976021T3 (pl) | 2019-05-30 | 2019-05-30 | Tri(beta-hydroksymaślan) glicerolu do zastosowania w leczeniu i zapobieganiu przemijającym atakom niedokrwiennym neuronów |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12239624B2 (pl) |
| EP (1) | EP3976021B1 (pl) |
| JP (1) | JP7403861B2 (pl) |
| KR (1) | KR20220016145A (pl) |
| CN (1) | CN113710243A (pl) |
| BR (1) | BR112021022763A2 (pl) |
| CA (1) | CA3136552C (pl) |
| ES (1) | ES3030344T3 (pl) |
| IL (1) | IL288343B2 (pl) |
| MX (1) | MX2021014546A (pl) |
| MY (1) | MY199307A (pl) |
| PL (1) | PL3976021T3 (pl) |
| WO (1) | WO2020242478A1 (pl) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4598203B2 (ja) | 1995-12-01 | 2010-12-15 | ビーティージー・インターナショナル・リミテッド | 脳機能改善剤 |
| US6316038B1 (en) | 1997-03-17 | 2001-11-13 | Btg International Limited | Therapeutic compositions |
| CA2283642C (en) | 1997-03-17 | 2012-05-15 | Btg International Limited | Therapeutic compositions |
| US6316938B1 (en) | 2000-04-08 | 2001-11-13 | Sergio Cecconi | Magnetic gauge for determining the thickness of filler used to repair vehicle damage |
| GB0420856D0 (en) | 2004-09-20 | 2004-10-20 | Ketocytonyx Inc | Cns modulators |
| US7807718B2 (en) | 2006-06-30 | 2010-10-05 | Sami A. Hashim | Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose |
| WO2008120778A1 (ja) * | 2007-03-30 | 2008-10-09 | Earthus, Inc. | ケトン体生成促進剤組成物 |
| BRPI0811052A2 (pt) * | 2007-04-12 | 2015-01-27 | Univ Minnesota | Composições de proteção de isquemia/reperfusão e métodos de uso. |
| US9125881B2 (en) * | 2008-07-03 | 2015-09-08 | Accera, Inc. | Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
| US20180200220A1 (en) * | 2015-07-10 | 2018-07-19 | Cognate Nutritionals, Inc. | Prophylaxis and mitigation of migraine headaches using ketogenic medium chain triglycerides, ketone esters, and other ketogenic sources |
| US20180177753A1 (en) * | 2016-12-23 | 2018-06-28 | Neuroenergy Ventures, Inc. | Glyceryl 3-hydroxybutyrates for migraine symptom management |
| US9925164B1 (en) * | 2017-01-12 | 2018-03-27 | Neuroenergy Ventures, Inc. | Glyceryl 3-hydroxybutyrates for traumatic brain injury |
-
2019
- 2019-05-30 PL PL19930919.6T patent/PL3976021T3/pl unknown
- 2019-05-30 CN CN201980095609.2A patent/CN113710243A/zh active Pending
- 2019-05-30 JP JP2021568387A patent/JP7403861B2/ja active Active
- 2019-05-30 MX MX2021014546A patent/MX2021014546A/es unknown
- 2019-05-30 KR KR1020217042604A patent/KR20220016145A/ko not_active Ceased
- 2019-05-30 ES ES19930919T patent/ES3030344T3/es active Active
- 2019-05-30 BR BR112021022763A patent/BR112021022763A2/pt unknown
- 2019-05-30 EP EP19930919.6A patent/EP3976021B1/en active Active
- 2019-05-30 IL IL288343A patent/IL288343B2/en unknown
- 2019-05-30 CA CA3136552A patent/CA3136552C/en active Active
- 2019-05-30 US US17/608,350 patent/US12239624B2/en active Active
- 2019-05-30 WO PCT/US2019/034592 patent/WO2020242478A1/en not_active Ceased
- 2019-05-30 MY MYPI2021005583A patent/MY199307A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7403861B2 (ja) | 2023-12-25 |
| JP2022537487A (ja) | 2022-08-26 |
| CA3136552C (en) | 2024-01-16 |
| MX2021014546A (es) | 2022-01-06 |
| CN113710243A (zh) | 2021-11-26 |
| IL288343A (en) | 2022-07-01 |
| IL288343B2 (en) | 2024-04-01 |
| EP3976021B1 (en) | 2025-04-16 |
| ES3030344T3 (en) | 2025-06-27 |
| CA3136552A1 (en) | 2020-12-03 |
| EP3976021A1 (en) | 2022-04-06 |
| US12239624B2 (en) | 2025-03-04 |
| BR112021022763A2 (pt) | 2022-01-11 |
| IL288343B1 (en) | 2023-12-01 |
| MY199307A (en) | 2023-10-24 |
| KR20220016145A (ko) | 2022-02-08 |
| EP3976021A4 (en) | 2022-11-09 |
| EP3976021C0 (en) | 2025-04-16 |
| WO2020242478A1 (en) | 2020-12-03 |
| US20220288006A1 (en) | 2022-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277343B1 (en) | "CD47-binding factors and their uses in the treatment of diseases" | |
| SG11202100835VA (en) | Random access method and related device | |
| GB2603710B (en) | Protecting workloads in kubernetes | |
| EP3310113A4 (en) | Random access method and equipment | |
| ZA201906236B (en) | Kits and methods for treating hair | |
| HUE067857T2 (hu) | Véletlen hozzáféréses eljárás és eszköz | |
| SG11202100034QA (en) | Backoff procedure in random access | |
| IL282824A (en) | Preparations and methods for treating transient biofilms | |
| ZA202006069B (en) | Random access method and device | |
| CO2017008129A2 (es) | Método para prevenir o tratar la pérdida de la audición | |
| PL3533281T3 (pl) | Sposoby i urządzenia dostępu losowego | |
| EP3955684A4 (en) | Random access method and apparatus | |
| IL273805A (en) | Preparations and methods for the treatment of diffuse large b-cell lymphoma | |
| EP3253766A4 (en) | Compounds and methods for preventing or treating sensory hair cell death | |
| SG11202105543XA (en) | Random access method and device | |
| IL275629A (en) | Inula helenium extracts for treating and preventing pollution related damage | |
| IL255582A (en) | Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase inhibitors | |
| PL3976021T3 (pl) | Tri(beta-hydroksymaślan) glicerolu do zastosowania w leczeniu i zapobieganiu przemijającym atakom niedokrwiennym neuronów | |
| EP3874893A4 (en) | METHODS AND DEVICES FOR DIRECT ACCESS | |
| EP3780752C0 (en) | ACCESS METHOD AND DEVICE | |
| GB201911754D0 (en) | System and method for providing least privilege access in a microservices architecture | |
| ZA202100525B (en) | Synergistically effective herbicide composition comprising pyridate and at least one defined 4-hppd inhibitor | |
| IL267534A (en) | Low dose drug combinations for use in preventing and treating neuronal damage | |
| SG11202102609VA (en) | Random access method and terminal | |
| EP3723766A4 (en) | COMPOSITION AND METHOD FOR THE TREATMENT, MITIGATION OR PREVENTION OF MUSCLE CRAMPS, CONTAINING CHOLINE ALFOSCERATE AS ACTIVE INGREDIENT |